Research & Development



  “都是把戲,無分大小!”   郭解笑吟吟的站在城下,仰著頭看著城牆上的一對璧人,堆著一張笑臉嘴里卻小聲的污言穢語不絕。水莓100视频   劉邦在建立西漢王朝以後,面對新的形勢,劉邦感到“三章之法不足以御奸”。人人妻在人人摸人人碰   何愁有是全大漢守規矩的典範,他自己制定的規則,早就被歷史證明是最能保護一個人的規則。   小丫頭的性子本身就是跳脫的,看似東一榔頭西一棒子的沒有個目的性,事實上,就雲瑯見過的那些搞研究的,哪一個不是這樣?caoporon免费超碰在线   在很久以前,雲瑯不知道這樣摟過多少女子的腰,一起看星星,或者一起看沙漠,就連一起看狗交配的時候都這樣做過。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo